Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 4110
MIM: 300344
HGNC: 6798
Ensembl: ENSG00000185247
Variants:
dbSNP: 4110
ClinVar: 4110
TCGA: ENSG00000185247
COSMIC: MAGEA11
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000185247 | ENST00000333104 | G5E962 |
| ENSG00000185247 | ENST00000355220 | P43364 |
| ENSG00000185247 | ENST00000412632 | C9J2X2 |
Expression (GTEx)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 36804154 | 2023 | The Disruption of Mage-11 Gene via CRISPR/Cas9 Method Induced Apoptosis in the in vitro Model of Prostate Cancer. | 0 |
| 36804154 | 2023 | The Disruption of Mage-11 Gene via CRISPR/Cas9 Method Induced Apoptosis in the in vitro Model of Prostate Cancer. | 0 |
| 35022469 | 2022 | Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer. | 5 |
| 36341564 | 2022 | Molecular Characteristics of Bladder Tumor: Increased Gene Expression of MAGE-A6 and MAGE-A11 with Decreased MicroRNA-34a and MicroRNA-125b. | 1 |
| 35022469 | 2022 | Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer. | 5 |
| 36341564 | 2022 | Molecular Characteristics of Bladder Tumor: Increased Gene Expression of MAGE-A6 and MAGE-A11 with Decreased MicroRNA-34a and MicroRNA-125b. | 1 |
| 31980388 | 2020 | A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex. | 34 |
| 32529260 | 2020 | Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma. | 12 |
| 33004795 | 2020 | Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases. | 13 |
| 31980388 | 2020 | A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex. | 34 |
| 32529260 | 2020 | Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma. | 12 |
| 33004795 | 2020 | Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases. | 13 |
| 31126819 | 2019 | Expression and prognostic significance of MAGE-A11 and transcription factors (SP1,TFCP2 and ZEB1) in ESCC tissues. | 8 |
| 31155488 | 2019 | Demethylation-mediated upregulation of melanoma-associated antigen-A11 correlates with malignant progression of esophageal squamous cell carcinoma. | 5 |
| 31256208 | 2019 | Delayed endometrial decidualisation in polycystic ovary syndrome; the role of AR-MAGEA11. | 21 |
Citation
Dessen P
MAGEA11 (MAGE family member A11)
Atlas Genet Cytogenet Oncol Haematol. 2003-06-01
Online version: http://atlasgeneticsoncology.org/gene/41243/magea11
